How mystery illnesses could threaten the global economic recovery: According to a new report, the global recovery could be in trouble unless there is an unprecedented outbreak of a mystery illness that has swept through the US.

The report by the consulting firm Avalere Health, found that the global GDP would be hurt by a significant increase in the number of mystery illnesses and that the number and severity of the illnesses could be a key indicator of how the economy will recover from this pandemic.

In the US alone, there have been more than 2,700 cases of mystery illness since February 1st, which has generated a lot of media attention.

But the Avalere study found that even though the US is the biggest economy in the world, it is unlikely that the pandemic will affect global economic growth in the near future.

The main reason why is the rapid rise in mystery illnesses that have swept through US cities and are spreading across the country.

While the number is still relatively small, the Avalemys study said that it is clear that it could lead to a large jump in the amount of money spent by Americans on healthcare.

While healthcare spending is a key driver of economic growth, the fact that mystery illnesses are becoming more prevalent is also an indicator that the recovery is being hit hard by the pandemics.

It is important to understand that the world is experiencing an extraordinary period of uncertainty, and the global response to the crisis has been slow, if not halting.

But if the pandemaker is not stopped soon, the world economy will face significant challenges in the next few years, Avalere warned.

According to Avalere, the main cause of the global recession was the lack of sufficient demand for healthcare.

The rise in the supply of healthcare goods, such as ambulatory surgery machines, pacemakers and oxygen masks, has meant that the demand for medical services has fallen.

So, while the number may not have risen as much as the previous crisis, the problem is that the healthcare supply is not sufficient to keep up with demand.

This has led to a shortage of medical supplies, and as a result, the demand has fallen further, the report said.

If the supply situation continues to deteriorate, and medical supplies are not replenished quickly enough, there will be a major economic and social impact on healthcare spending.

It would also be important to ensure that there are adequate health resources to address any unforeseen and unexpected emergencies, such to the rise in mysterious illness rates.

This is why the United Nations has been warning of an “urgent and prolonged humanitarian emergency” in the event that the crisis does not stop.

The US is one of the most important markets for medical supplies.

The United States, along with China and Canada, is responsible for around a third of global healthcare spending, with the United Kingdom and Australia being the second and third largest markets.

But even though medical supplies have increased substantially, they have not kept up with the growth of the demand.

The United States has the third-highest number of mysterious illnesses in the OECD, after Germany and Canada.

While it is expected that the United States will see the biggest rise in healthcare spending as a direct result of the pandeman, the United states also faces the risk of a significant drop in healthcare exports.

According a recent report by Avalere and PricewaterhouseCoopers, the US has seen a fall in the global healthcare exports rate to US$1.7 trillion (£1.3 trillion) in 2016.

As a result of this, the amount the US will need to import healthcare products is likely to fall by about $200 billion.

If this trend continues, it would mean that the US economy would lose around $400 billion in healthcare imports, according to Avalem.

A number of countries have warned the United State not to rush into a rush to import the medications as there are currently no available medicines for these patients.

In addition, there are concerns about the supply and safety of some medicines.

In response to this, China has been encouraging healthcare suppliers to increase their import capacity, and has promised to spend more on medical supplies if the US does not speed up its importation.